192130-06-6

Basic information

• Product Name: 4-(2-HYDROXYETHYLAMINO)-PYRIDINE
• Synonyms: 4-(2-HYDROXYETHYLAMINO)-PYRIDINE;Ethanol, 2-(4-pyridinylamino)- (9CI);4-(2-HYDROXYETHYLAMINO)-PYRIDINE >98%
• CAS NO: 192130-06-6
• Molecular Formula: C₇H₁₀N₂O
• Molecular Weight: 138.17
• Product Categories: PYRIDINE
• Mol File: 192130-06-6.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 322.2 °C at 760 mmHg
• Flash Point: 148.7 °C
• Appearance: /
• Density: 1.189 g/cm³
• Vapor Pressure: 0.000117mmHg at 25°C
• Refractive Index: 1.607
• CAS DataBase Reference: 4-(2-HYDROXYETHYLAMINO)-PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-HYDROXYETHYLAMINO)-PYRIDINE(192130-06-6)
• EPA Substance Registry System: 4-(2-HYDROXYETHYLAMINO)-PYRIDINE(192130-06-6)

Safety Data

• Hazardous Substances Data: 192130-06-6(Hazardous Substances Data)

Usage

General Description

4-(2-Hydroxyethylamino)-pyridine is a chemical compound with the formula C7H10N2O. It is a pyridine derivative that contains an amino group and a hydroxyethyl group attached to the pyridine ring. 4-(2-HYDROXYETHYLAMINO)-PYRIDINE is commonly used as a building block in the synthesis of various pharmaceuticals and agrochemicals. It has also been studied for its potential as a corrosion inhibitor for metal surfaces. 4-(2-Hydroxyethylamino)-pyridine is a versatile and important chemical intermediate with various applications in the fields of chemistry and materials science.

InChI:InChI=1/C7H10N2O/c10-6-5-9-7-1-3-8-4-2-7/h1-4,10H,5-6H2,(H,8,9)

Upstream product

• 626-61-9 4-Chloropyridine 
• 141-43-5 ethanolamine 

Downstream Products

• 22731-70-0 1-(4-bromophenyl)prop-2-en-1-one 
• 170434-10-3 4-bromo-1-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctyloxy)benzene 
• 238099-24-6 1-(4-bromophenyl)-2-ferrocenylacetylene 
• 403819-41-0 1-(1'-acetylferrocen-1-ylethynyl)-4-bromobenzene 
• 403819-27-2 1,4-bis-(1'-acetyl-1-ethynylferrocen-1-yl)-1,3-butadiyne 
• 690264-67-6 [2-(4-bromo-phenoxy)-ethyl]-pyridin-4-yl-amine 

Relevant articles and documents

SUBSTITUTED QUINAZOLINE DERIVATIVES AS DNA METHYLTRANSFERASE INHIBITORS

The present invention relates to compounds of the following formula (I) and pharmaceutically acceptable salts and solvates thereof, their methods of preparation, their use as a drug, notably in the treatment of cancer, and pharmaceutical compositions containing such compounds.

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

The present invention relates to alkyne compounds of general formula I wherein the groups and residues A, B, W, X, Y, Z, R1 and R2 have the meanings given in claim 1. The invention further relates to pharmaceutical compositions containing at least one alkyne according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.

SUBSTITUTED QUINAZOLINES

-